Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: Prevalence and risk factors

International Journal of Diabetes and Metabolism

Volumn 14, Issue 3, 2006, Pages 126-133

  Janghorbani, Mohsen ^a,b   Rezvanian, Hasan ^a   Kachooei, Ali ^a   Ghorbani, Abbas ^a   Chitsaz, Ahmad ^a   Izadi, Farzad ^a   Amini, Masoud ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Complications; Diabetes mellitus; Diabetic neuropathy; Epidemiology; Iran; Peripheral neuropathy; Prevalence; Risk factors

Indexed keywords

INSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; IRAN; ISCHEMIC HEART DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT DEPARTMENT; PERIPHERAL NEUROPATHY; PREVALENCE; PROTEINURIA; RETINOPATHY; RISK FACTOR;

EID: 34249021156     PISSN: 16067754     EISSN: None     Source Type: Journal    
DOI: 10.1159/000497604     Document Type: Article

References (39)

1. Edmonds ME, Blundell MP, Morris ME, et al. Improved survival of the diabetic foot: the role of a specialised foot clinic. Q J Med 1986; 60: 763-771.
2. Paisey RB, Arredondo G, Villalobos A, et al. Association of differing dietary metabolic and clinical risk factors with microvascular complications of diabetes: a prevalence study of 503 Mexican type II diabetic subjects. II. Diabetes Care 1984; 7: 428-433.
3. Veves A, Manes C, Murray HJ, Young MJ, Boulton AJM. Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care 1993; 16:1187-1189.
4. Young MJ, Boulton AJM, Macleod AF, Williams DRR, Sonsken PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36:150-154.
5. Ratzmann KP, Raschke M, Gander I, Schimke E. Prevalence of peripheral and autonomic neuropathy in newly diagnosed type II (non-insulin-dependent) diabetes. J Diabetes Complications 1991; 5:1-5.
6. Knuiman MW, Welborn TA, McCann VJ, et al. Prevalence of diabetic complications in relation to risk factors. Diabetes 1986; 35:1332-1339.
7. Lehtinen JM, Uusitupa M, Siitonen O, Pyorala K. Prevalence of neuropathy in newly diagnosed NIDDM and non-diabetic control subjects. Diabetes 1989; 38:1307-1313.
8. Franklin GM, Kahn LB, Baxter J, et al. Sensory neuropathy in non-insulin-dependent diabetes mellitus: The San Luis Valley Diabetes Study. Am J Epidemiol 1990; 131: 633-643.
9. Walters DP, Gatling W, Mullee MA, Hill RD. The prevalence of diabetic distal sensory neuropathy in an English community. Diabet Med 1992; 9:349-353.
10. Verhoeven S, van Ballegooie E, Casparie AF. Impact of late complications in type 2 diabetes in a Dutch population. Diabet Med 1991; 8: 435-438.
11. Harris MI, Eastman R, Cowie C. Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population. Diabetes Care 1993; 16:1446-1452.
12. Dyck PJ, Kratz KM, Kames JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993; 43:817-824.
13. Melton LJ III, Dyck PJ. Epidemiology In: Dyck PJ, Thomas PK, Asbury AK, Winegrad Al, Porte D Jr., (eds.): Diabetic Neuropathy. Philadelphia, Saunders: 27-35 15; 1987.
14. Palumbo PJ, Elveback LR, Whisnant JP. Neurologic complications of diabetes mellitus: transient ischemic attack, stroke, and peripheral neuropathy. Adv Neurol 1978; 19:593601.
15. Pirart J. Diabetes and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1978; 1:168-188.
16. Thomas PK, Eliasson SG. Diabetic neuropathy In: Dyck PJ, Thomas PK, Asbury A, Weingrad A, Porte D Jr., (eds.): Diabetic Neuropathy Philadelphia, Saunders: 1773-1810; 1987.
17. Rate RG, Knowler WC, Morse HG, et al. Diabetes mellitus in Hopi and Navajo Indians: prevalence of microvascular complications. Diabetes 1983; 32:894-899.
18. Janghorbani M, Amini M, Ghanbari H, Safaiee H. Incidence of and risk factors for diabetic retinopathy in Isfahan, Iran. Ophthalmic Epidemiology 2003; 10:81-95.
19. Janghorbani M, Amini M. Cataract in type 2 diabetes mellitus in Isfahan, Iran: Incidence and risk factors. Ophthalmic Epidemiology 2004; 11:347-358.
20. The DCCT Research Group. Factors in the development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). Diabetes 1988; 37:476-481.
21. Ward JD. Diabetic neuropathy. In: Williams R, Papoz L, Fuller JH (eds.): Diabetes in Europe. John Libbey and Company Ltd/Editions INSERM: 1994; 72-77..
22. Kimura J. Electrodiagnosis in Diseases of the Nerve and Muscle: Principles and practice. Davis, Philadelphia: 103-138; 1989.
23. Tesfaye S, Stevens LK, Stephenson JM, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996; 39: 1377-1384.
24. Partanen J, Niskanen L, Lehtinen J, et al. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 13:333:89-94.
25. Boru UT, Alp R, Sargin H, et al. Prevalence of peripheral neuropathy in type 2 diabetic patients attending a diabetes center in Turkey. Endocrine J 2004; 51: 563-567.
26. Rota E, Quadri R, Fanti E, et al. Electrophysiological findings of peripheral neuropathy in newly diagnosed type II diabetes mellitus. J Peripher Nerv Syst 2005; 10:348-53.
27. Maser RE, Steenkiste AR, Dorman JS, et al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 1989; 38:1456-1461.
28. Ellenberg M . Diabetic neuropathy: a consideration of factors in onset. Ann Intern Med 1960; 52:1067-1075.
29. Walkamatsu H, Anazawa W, Hirose H. Motor nerve conduction velocity in diabetes mellitus: relationship with arteriosclerosis, blood sugar, arterial blood pH, serum electrolytes and tissue temperature. Electromyography 1967; 7:185-186.
30. Tackmann W, Kaeser HE, Berger W, Rueger AN. Sensory and motor parameters in leg nerves of diabetic inter-correlations and relationship to clinical symptom. Euro Neurol 1981; 20:344-350.
31. Hoffman WH, Hart ZH, Frank RN. Correlate of delayed motor nerve conduction and retinopathy in juvenile onset diabetes mellitus. J Pediatr 1983; 3:351-356.
32. Ziegler D, Cicmir I, WiefelsK, Berger H, Gries FA. Peripheral and autonomic nerves function in long-term insulin-dependent diabetes. Diabetes Res 1987; 4:9-14.
33. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
34. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352:854-865
35. Klein R, Klein BE, Moss SE. Relation of glycaemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med 1996; 124:90-96.
36. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:837-853.
37. Franklin GM, Shetterly SM, Cohen JA, Baxter J, Hamman RF. Risk factors for distal symmetry neuropathy in NIDDM: The San Luis Valley Diabetes Study. Diabetes Care 1994; 17:1172-1177.
38. Mitchell BD, Hawthorne VM, Vinik AI. Cigarette smoking and neuropathy in diabetic patients. Diabetes Care 1990; 13:434-437.
39. Lehtinen JM, Niskanen L, Hyvonen K, Siitonen O, Uusitupa M. Nerve function and its determinants in patients with newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus and in control subjects: a 5-year follow-up. Diabetologia 1993; 36:68-72.